US Bancorp DE reduced its holdings in shares of Relx Plc (NYSE:RELX – Free Report) by 1.9% in the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 261,010 shares of the technology company’s stock after selling 5,172 shares during the quarter. US Bancorp DE’s holdings in Relx were worth $11,855,000 at the end of the most recent reporting period.
Several other institutional investors and hedge funds have also modified their holdings of the business. FMR LLC lifted its position in shares of Relx by 8.3% during the 3rd quarter. FMR LLC now owns 7,148,837 shares of the technology company’s stock worth $339,284,000 after buying an additional 548,423 shares during the last quarter. Captrust Financial Advisors raised its position in Relx by 3.4% in the third quarter. Captrust Financial Advisors now owns 1,103,797 shares of the technology company’s stock valued at $52,386,000 after purchasing an additional 35,807 shares during the last quarter. JPMorgan Chase & Co. raised its position in Relx by 14.6% in the third quarter. JPMorgan Chase & Co. now owns 826,481 shares of the technology company’s stock valued at $39,225,000 after purchasing an additional 104,999 shares during the last quarter. Reynders McVeigh Capital Management LLC raised its position in Relx by 31.8% in the third quarter. Reynders McVeigh Capital Management LLC now owns 495,004 shares of the technology company’s stock valued at $23,493,000 after purchasing an additional 119,405 shares during the last quarter. Finally, AEGON ASSET MANAGEMENT UK Plc raised its position in Relx by 2.7% in the fourth quarter. AEGON ASSET MANAGEMENT UK Plc now owns 280,889 shares of the technology company’s stock valued at $12,755,000 after purchasing an additional 7,289 shares during the last quarter. 15.02% of the stock is currently owned by institutional investors.
Relx Price Performance
Relx stock opened at $48.50 on Tuesday. Relx Plc has a 12 month low of $40.25 and a 12 month high of $51.99. The company has a current ratio of 0.52, a quick ratio of 0.47 and a debt-to-equity ratio of 1.46. The company has a market capitalization of $90.14 billion, a PE ratio of 26.08, a P/E/G ratio of 2.73 and a beta of 0.90. The stock has a 50-day moving average price of $48.42 and a two-hundred day moving average price of $47.49.
Relx Increases Dividend
Analysts Set New Price Targets
Several research firms have commented on RELX. Redburn Atlantic began coverage on Relx in a research report on Wednesday, January 8th. They issued a “buy” rating for the company. StockNews.com downgraded Relx from a “buy” rating to a “hold” rating in a research report on Tuesday.
Check Out Our Latest Analysis on Relx
Relx Profile
RELX Plc engages in provision of information and analytics solutions for professional and business customers across industries. It operates through the following business segments: Scientific, Technical & Medical; Risk & Business Analytics; Legal; and Exhibitions. The Scientific, Technical & Medical segment is a global information analytics business that helps institutions and professionals advance healthcare, open science, and improve performance for the benefit of humanity.
Read More
- Five stocks we like better than Relx
- What Are the U.K. Market Holidays? How to Invest and Trade
- Bearish Investors Can Seek Refuge in Recession-Resistant ETFs
- Golden Cross Stocks: Pattern, Examples and Charts
- 3 Oversold Magnificent Seven Stocks at Key Levels: Buy Now?
- 3 Small Caps With Big Return Potential
- 3M to Hit $175 by Mid-Year, and Higher Highs Are Likely
Want to see what other hedge funds are holding RELX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Relx Plc (NYSE:RELX – Free Report).
Receive News & Ratings for Relx Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Relx and related companies with MarketBeat.com's FREE daily email newsletter.